Results 211 to 220 of about 24,056 (240)
Some of the next articles are maybe not open access.

Involvement of organic cation transporter 1 and CYP3A4 in retrorsine-induced toxicity

Toxicology, 2014
Retrorsine (RTS) is a hepatotoxic pyrrolizidine alkaloid present in plants of the Senecio genus. The present study is aimed at clarifying the role of organic cation transporters (OCTs) in the liver disposition of RTS, and the coupling of OCT1 and cytochrome P450 (CYP) 3A4 in the hepatotoxicity of RTS.
Meijuan, Tu   +9 more
openaire   +2 more sources

Organic Cation Transporter 1 and 3 Contribute to the High Accumulation of Dehydrocorydaline in the Heart

Drug Metabolism and Disposition, 2020
Dehydrocorydaline (DHC), one of the main active components of Corydalis yanhusuo, is an important remedy for the treatment of coronary heart disease. Our previous study revealed a higher unbound concentration of DHC in the heart than plasma of mice after oral administration of C.
Yingchun, Chen   +6 more
openaire   +2 more sources

Interactions of human organic anion transporters 1–4 and human organic cation transporters 1–3 with the stimulant drug methamphetamine and amphetamine

Legal Medicine, 2020
Drug membrane transport system proteins, namely, drug transporters, are expressed in the kidney and liver and play a crucial role in the excretion process. This study aimed to elucidate the interactions of the drug transporters human organic anion transporters 1, 2, 3, 4 (hOAT1, 2, 3, 4) and human organic cation transporters 1, 2, 3 (hOCT1, 2, 3 ...
Shoetsu, Chiba   +4 more
openaire   +2 more sources

Pharmacokinetic interactions of niclosamide in rats: Involvement of organic anion transporters 1 and 3 and organic cation transporter 2

Chemico-Biological Interactions
Niclosamide is an anthelmintic drug with a long history of use and is generally safe and well tolerated in humans. As the conventional dose of niclosamide results in a low but certain level in systemic circulation, drug interactions with concomitant drugs should be considered.
Min-Ji Kang   +5 more
openaire   +3 more sources

Abstract 257: Evaluation of organic cation transporter 1 (OCT1, SLC22A1) as transporter for sorafenib

Cancer Research, 2016
Abstract The multikinase inhibitor sorafenib is approved for the treatment of advanced clear-cell renal and hepatocellular carcinomas, yet, patients’ survival is prolonged for only several months (Wilhelm et al., Mol Cancer Ther 2008). The understanding of this poor efficacy remains incomplete. One reason for treatment failure may be the
Claudia Neul   +6 more
openaire   +1 more source

OCT-1, Organic Cation Transporter 1

2007
Valentin Gorboulev, Hermann Koepsell
openaire   +1 more source

Polymorphisms of organic cation transporter 1 and the drugs response

2015
Polymorphisms of proteins which have an important role in drug transport, metabolism, and disposition in the bodycould affect the drugs efficacy and toxicity. The organic cation transporter 1 (OCT1), encoded by SLC22A1 gene,has been known as one of the polyspecific protein transporters which could affect some of the cationic drugresponse such as ...
openaire   +1 more source

Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.

Diabetes, 2008
The uptake of drugs into hepatocytes is a key determinant for hepatic metabolism, intrahepatic action, their subsequent systemic plasma concentrations, and extrahepatic actions. In vitro and in vivo studies indicate that many drugs used for treatment of cardiovascular diseases (e.g., oral antidiabetic drugs, statins) are taken up into hepatocytes by ...
Iouri, Bachmakov   +3 more
openaire   +1 more source

Cloning and Functional Expression of a Human Liver Organic Cation Transporter

Molecular Pharmacology, 1997
Mark J Dresser   +2 more
exaly  

Home - About - Disclaimer - Privacy